低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔片治疗重度妊高征的临床研究

Hongyou Chen, Lihua Song, Fei Wang, Yan Gao, Shuang Zhang
{"title":"低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔片治疗重度妊高征的临床研究","authors":"Hongyou Chen, Lihua Song, Fei Wang, Yan Gao, Shuang Zhang","doi":"10.26689/aogr.v1i1.5058","DOIUrl":null,"url":null,"abstract":"Objective: To investigate the clinical effect of low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension. Methods: A total of 48 patients with severe pregnancy-induced hypertension admitted from February 2021 to February 2023 were selected, and the patients were divided into two groups by simple sampling, with 24 cases in each group. Patients in the control group received labetalol orally and intravenous infusion of magnesium sulfate, whereas those in the observation group received subcutaneous injection of low molecular weight heparin sodium on the basis of the control group. The two groups of patients underwent 5 days of treatment, and the blood pressure control, vascular endothelial function, renal function, and blood coagulation were compared between the two groups. Results: Before treatment, there were no significant differences in blood pressure readings, endothelin-1 (ET-1) and nitric oxide (NO) levels, serum creatinine (SCr) and blood urea nitrogen (BUN) levels, and the four coagulation indices between the two groups (all P > 0.05). After treatment, the blood pressure readings in the observation group were lower than those in the control group (P < 0.05); ET-1 in the observation group was lower than that in the control group, and the NO level in the observation group was higher than that in the control group (P < 0.05); compared with the control group, the observation group had lower SCr and BUN (P < 0.05), longer prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), and lower fibrinogen (Fib) level (P < 0.05). Conclusion: Low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension can help control blood pressure levels, promote the recovery of vascular endothelial function and renal function, and effectively correct coagulation function.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Clinical Study of Low Molecular Weight Heparin Sodium Injection Combined with Magnesium Sulfate Injection and Labetalol Tablets in the Treatment of Severe Pregnancy-Induced Hypertension\",\"authors\":\"Hongyou Chen, Lihua Song, Fei Wang, Yan Gao, Shuang Zhang\",\"doi\":\"10.26689/aogr.v1i1.5058\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To investigate the clinical effect of low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension. Methods: A total of 48 patients with severe pregnancy-induced hypertension admitted from February 2021 to February 2023 were selected, and the patients were divided into two groups by simple sampling, with 24 cases in each group. Patients in the control group received labetalol orally and intravenous infusion of magnesium sulfate, whereas those in the observation group received subcutaneous injection of low molecular weight heparin sodium on the basis of the control group. The two groups of patients underwent 5 days of treatment, and the blood pressure control, vascular endothelial function, renal function, and blood coagulation were compared between the two groups. Results: Before treatment, there were no significant differences in blood pressure readings, endothelin-1 (ET-1) and nitric oxide (NO) levels, serum creatinine (SCr) and blood urea nitrogen (BUN) levels, and the four coagulation indices between the two groups (all P > 0.05). After treatment, the blood pressure readings in the observation group were lower than those in the control group (P < 0.05); ET-1 in the observation group was lower than that in the control group, and the NO level in the observation group was higher than that in the control group (P < 0.05); compared with the control group, the observation group had lower SCr and BUN (P < 0.05), longer prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), and lower fibrinogen (Fib) level (P < 0.05). Conclusion: Low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension can help control blood pressure levels, promote the recovery of vascular endothelial function and renal function, and effectively correct coagulation function.\",\"PeriodicalId\":269611,\"journal\":{\"name\":\"Advances in Obstetrics and Gynecology Research\",\"volume\":\"28 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Obstetrics and Gynecology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26689/aogr.v1i1.5058\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Obstetrics and Gynecology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26689/aogr.v1i1.5058","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔治疗重度妊高征的临床疗效。方法:选择2021年2月~ 2023年2月收治的重症妊高征患者48例,采用简单抽样法分为两组,每组24例。对照组患者口服拉贝他洛尔并静脉滴注硫酸镁,观察组患者在对照组的基础上皮下注射低分子肝素钠。两组患者均治疗5 d,比较两组患者血压控制、血管内皮功能、肾功能、凝血情况。结果:治疗前,两组患者血压、内皮素-1 (ET-1)、一氧化氮(no)水平、血清肌酐(SCr)、尿素氮(BUN)水平及凝血四项指标比较,差异均无统计学意义(P > 0.05)。治疗后,观察组患者血压读数低于对照组(P < 0.05);观察组患者ET-1水平低于对照组,NO水平高于对照组(P < 0.05);观察组患者SCr、BUN低于对照组(P < 0.05),凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)延长,纤维蛋白原(Fib)水平低于对照组(P < 0.05)。结论:低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔治疗重度妊高增高,有助于控制血压水平,促进血管内皮功能和肾功能恢复,有效纠正凝血功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Clinical Study of Low Molecular Weight Heparin Sodium Injection Combined with Magnesium Sulfate Injection and Labetalol Tablets in the Treatment of Severe Pregnancy-Induced Hypertension
Objective: To investigate the clinical effect of low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension. Methods: A total of 48 patients with severe pregnancy-induced hypertension admitted from February 2021 to February 2023 were selected, and the patients were divided into two groups by simple sampling, with 24 cases in each group. Patients in the control group received labetalol orally and intravenous infusion of magnesium sulfate, whereas those in the observation group received subcutaneous injection of low molecular weight heparin sodium on the basis of the control group. The two groups of patients underwent 5 days of treatment, and the blood pressure control, vascular endothelial function, renal function, and blood coagulation were compared between the two groups. Results: Before treatment, there were no significant differences in blood pressure readings, endothelin-1 (ET-1) and nitric oxide (NO) levels, serum creatinine (SCr) and blood urea nitrogen (BUN) levels, and the four coagulation indices between the two groups (all P > 0.05). After treatment, the blood pressure readings in the observation group were lower than those in the control group (P < 0.05); ET-1 in the observation group was lower than that in the control group, and the NO level in the observation group was higher than that in the control group (P < 0.05); compared with the control group, the observation group had lower SCr and BUN (P < 0.05), longer prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), and lower fibrinogen (Fib) level (P < 0.05). Conclusion: Low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension can help control blood pressure levels, promote the recovery of vascular endothelial function and renal function, and effectively correct coagulation function.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信